# Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

> **NCT06302049** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sadat City University** · enrollment: 46 (estimated)

## Conditions studied

- Fatty Liver Disease
- Steatohepatitis, Nonalcoholic

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06302049
- **Lead sponsor:** Sadat City University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06302049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06302049, "Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06302049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*